Wellbutrin Indirect Buyers Seek Cert. In Antitrust Suit

A group of employee benefit plans has moved to certify a class of plaintiffs that paid or reimbursed for Wellbutrin XL, in an action accusing Biovail Corp. and GlaxoSmithKline PLC of...

Already a subscriber? Click here to view full article